Provided by Tiger Trade Technology Pte. Ltd.

Camp4 Therapeutics Corp.

4.32
-0.1600-3.57%
Post-market: 4.320.00000.00%16:10 EDT
Volume:109.48K
Turnover:477.04K
Market Cap:271.09M
PE:-1.94
High:4.52
Open:4.46
Low:4.26
Close:4.48
52wk High:7.75
52wk Low:1.41
Shares:62.75M
Float Shares:37.87M
Volume Ratio:0.38
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2250
EPS(LYR):-2.6500
ROE:-545.85%
ROA:-45.25%
PB:-391.19
PE(LYR):-1.63

Loading ...

Camp4 Therapeutics price target raised to $9 from $8 at Leerink

TIPRANKS
·
Apr 02

Canadian GoldCamps Secures Option to Acquire Majority Stake in Stelmine’s Québec Gold Projects

TIPRANKS
·
Apr 02

Open-Sourcing to Empower, AI to Lead Medicine: "SurgMotion", the Best-in-class Surgical Video Foundation Model, Officially Launched

prnewswire
·
Mar 25

CAMP4 Therapeutics Adds Veteran CFO MacLean to Board

TIPRANKS
·
Mar 24

Camp4 appoints Michael MacLean to board, expands board to nine directors

Reuters
·
Mar 24

Camp4 Appoints Michael Maclean to Its Board of Directors

THOMSON REUTERS
·
Mar 24

Press Release: CAMP4 Appoints Michael MacLean to its Board of Directors

Dow Jones
·
Mar 24

CAMP4 Therapeutics Up Over 62%, on Pace for Largest Percent Increase Since December 2024 -- Data Talk

Dow Jones
·
Mar 10

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:38 PM

Reuters
·
Mar 10

Camp4 Therapeutics to Present at Stifel CNS Forum

Reuters
·
Mar 07

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Cooper Co (COO) and CAMP4 Therapeutics Corporation (CAMP)

TIPRANKS
·
Mar 06

CAMP4 Therapeutics Corporation (CAMP) Receives a Buy from Piper Sandler

TIPRANKS
·
Mar 06

CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress

TIPRANKS
·
Mar 06

Camp4 Therapeutics Q4 EPS $(0.87) Misses $(0.30) Estimate, Sales $348.000K Miss $538.000K Estimate

Benzinga Earnings
·
Mar 06

Camp4 Therapeutics FY 2025 research and collaboration revenue rises 436.5% to USD 3.5 million

Reuters
·
Mar 06

CAMP4 FY 2025 net loss USD 80.4 million widens 55.2%

Reuters
·
Mar 06

Camp4 Therapeutics Corp FY Operating Expenses USD 56.053 Million

THOMSON REUTERS
·
Mar 06

Camp4 Therapeutics Corp FY Income From Operations USD -52.555 Million

THOMSON REUTERS
·
Mar 06

Press Release: CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights

Dow Jones
·
Mar 06

Cantor Fitzgerald Remains a Buy on CAMP4 Therapeutics Corporation (CAMP)

TIPRANKS
·
Feb 24